| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Department of Obstetrics, Gynecology, and Reproductive Sciences (N.A.C., S.H.M.), the Metabolic Research Unit (S.H.M.), and the Department of Pediatrics (E.S., L.J.S.), University of California, San Francisco, California 94143; and Universidad de La Laguna (E.S.), Laguna, Spain
Address all correspondence and requests for reprints to: Synthia H. Mellon, Ph.D., Department of Obstetrics and Gynecology, University of California, Box 0556, San Francisco, California 94143-0556.
Neurosteroids are steroids that are synthesized de novo
in the brain from cholesterol and, in general, mediate their effects
through ion-gated channel receptors such as
-aminobutyric
acidA (GABAA) and
N-methyl-D-aspartate receptors rather than
through classical nuclear steroid hormone receptors. Steroid hormones
are known to exist not only as free compounds, but also as sulfated
derivatives. Pharmacological studies indicate that unconjugated and
sulfated steroids, such as pregnenolone and pregnenolone sulfate, may
have opposite effects on GABAA receptors. Thus,
pregnenolone acts as a potent positive allosteric modulator of
-aminobutyric acid action at GABAA receptors, whereas
pregnenolone sulfate acts as a potent negative modulator. Recent
experiments also suggest that dehydroepiandrosterone and
dehydroepiandrosterone sulfate may have distinct effects on growth of
neurites from embryonic neocortical neurons in vitro.
Thus, regulation of steroid sulfation may have profound behavioral and
morphological effects on the nervous system. We, therefore, studied the
developmental expression of the enzyme steroid sulfatase (STS), which
converts sulfated steroids to free steroids. By in situ
hybridization, STS messenger RNA was expressed in the embryonic mouse
cortex, hindbrain, and thalamus during the last third of gestation. The
sites of expression of STS were similar to those of P450c17, suggesting
that these two enzymes may have concerted actions in similar functional
processes.
This article has been cited by other articles:
![]() |
F. Hammer, N. A. Compagnone, J.-L. Vigne, S. R. Bair, and S. H. Mellon Transcriptional Regulation of P450scc Gene Expression in the Embryonic Rodent Nervous System Endocrinology, February 1, 2004; 145(2): 901 - 912. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Compagnone, P. Zhang, J.-L. Vigne, and S. H. Mellon Novel Role for the Nuclear Phosphoprotein SET in Transcriptional Activation of P450c17 and Initiation of Neurosteroidogenesis Mol. Endocrinol., June 1, 2000; 14(6): 875 - 888. [Abstract] [Full Text] |
||||
![]() |
A. G. Mensah-Nyagan, J.-L. Do-Rego, D. Beaujean, V. Luu-The, G. Pelletier, and H. Vaudry Neurosteroids: Expression of Steroidogenic Enzymes and Regulation of Steroid Biosynthesis in the Central Nervous System Pharmacol. Rev., March 1, 1999; 51(1): 63 - 82. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Compagnone and S. H. Mellon Dehydroepiandrosterone: A potential signalling molecule for neocortical organization during development PNAS, April 14, 1998; 95(8): 4678 - 4683. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |